PHYSICIANS - Center of Biomedical Research Excellence (COBRE)

2003:

1. Kim B-C, Kim HT, Park SH, Cha J-S, Yufit T, Kim S-J, Falanga V: Fibroblasts from chronic wounds show altered TGF-β Type II receptor expression. J Cell Physiol. 2003;195: 331- 336.
   
2. Pang L, Reddy PV, McAuliffe CI, Colvin G, et al. Studies on BrdU labeling of hematopoietic cells: stem cells and cell lines. J Cell Physiol. 2003;197: 251-260.
   
3. Abedi M, Greer D, Lambert JF, Colvin GA, et al. Tolerance induction by costimulator blockade in 100 cGy treated hosts with varying degrees of genetic disparity. Leukemia. 2003;17: 1871-1879.
   
4. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P: Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 196:245-250, 2003.
   
5. Badiavas E, Falanga V: Treatment of chronic wounds with bone marrow derived cells. Arch Dermatol 2003: 139:510-516.
   
6. Colvin GA, Elfenbein GJ. The latest treatment advances for acute myelogenous leukemia. Med Health R. 2003;86: 243-246.
   
7. Colvin GA, Rathore R, Lambert J-F, Abedi M, et al. HLA-Haploidentical Stem Cell Infusions For Refractory Hematologic Malignancies: A Universal O
8. Outpatient Immunotherapeutic Approach in 100 cGy Treated Patients. In: Autologous Blood and Marrow Transplantation, Proceedings of the 11th International Symposium of Autologous Blood and Marrow Transplantation 2003; Edited by: Karel A. Dicke & Armand Keating, Carden Jennings Publishing Co., Ltd. December 2003.
   
9. Donohue K, Falanga V. Healing rate as a prognostic indicator of complete healing: A reappraisal. Wounds. 2003;15: 71-76.
   
10. Lambert JF, Liu M, Colvin GA, Dooner M, et al. Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. J Exp Med. 2003;197: 1563-1572.
11. Lum LG, Rathore R, Cummings F, Colvin GA, et al. Phase I/II study of treatment of stage IV breast cancer with OKT3 x trastuzumab-armed activated T cells. Clin Breast Cancer. 2003;4: 212-217.
    
12. Mogi M, Yang J, Lambert JF, Colvin GA, Shiojima I, et al. Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J Biol Chem. 2003;278: 39068-39075.
    
13. Falanga V: Mechanisms of cutaneous wound repair. In Fitzpatrick's Dermatology in General Medicine, eds. Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Sixth Edition. McGraw-Hill, New York, NY, 2003, pp. 236-246.
    
14. Quesenberry PJ, Colvin GA, Abedi M, Lambert JF, Moore B, Demers D, Greer D, McAuliffe C, Dooner M, Lum LG, Badiavas E, Falanga V. The marrow stem cell: the continuum. Bone Marrow Transplant. 2003;32: S19-22.
    
15. Roeder I, Loeffler M, Quesenberry PJ, Colvin GA, Lambert JF. Quantitative tissue stem cell modeling. Blood. 2003;102: 1143-1145.
    
16. Boden, D., Pusch, O., Lee, F., Tucker, L., Shank, P.R., Ramratnam, B. Promoter choice affects the potency of HIV-1 specific RNA interference. Nucleic Acids Research. 2003;31: 5033-5038.
    
17. Boden, D., Pusch, O., Lee, F., Tucker, L., Shank, P., Ramratnam, B. Nucleotide sequence homology requirements of HIV-1 specific shRNA. Nucleic Acids Research. 2003;31: 6444-6449.
    
18. Boden, D., Pusch, O., Lee, F., Tucker, L., Ramratnam, B. HIV-1 escape from RNA interference. Journal of Virology. 2003;77: 11531-11535.